You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T/NK-cell

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Peripheral T Cell Lymphoma Trial in Zhengzhou (SHR0302)

Not yet recruiting
  • Peripheral T Cell Lymphoma
  • Zhengzhou, Henan, China
    Henan cancer hospital
Jun 2, 2023

Peripheral T/NK Cell Lymphoma (R/R PTCL) Trial (YY-20394)

Recruiting
  • Peripheral T/NK Cell Lymphoma (R/R PTCL)
  • Houston, Texas
    MD Anderson Cancer Center
Oct 19, 2022

Extranodal NK T Cell Lymphoma, NK-Cell Leukemia Trial in Xuzhou (Anti-CD56 CAR T)

Recruiting
  • Extranodal NK T Cell Lymphoma
  • NK-Cell Leukemia
  • Anti-CD56 CAR T
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Jul 10, 2023

NK-T-Cell Lymphoma, Extranodal Trial in Shanghai (4 cycles of ESA regimen with sandwiched radiotherapy, 2 cycles of ESA regimen

Not yet recruiting
  • NK-T-Cell Lymphoma, Extranodal
  • 4 cycles of ESA regimen with sandwiched radiotherapy
  • +2 more
  • Shanghai, Shanghai, China
    Ruijin Hospital
Sep 29, 2023

T-Cell and NK-Cell Tumor Trial

Not yet recruiting
  • T-Cell and NK-Cell Neoplasm
    • (no location specified)
    Sep 28, 2023

    nk/T-cell Lymphoma, Newly Diagnosed, Advanced Lymphoma Trial in Beijing (XPO1 inhibitor)

    Recruiting
    • nk/T-cell Lymphoma
    • +2 more
    • XPO1 inhibitor
    • Beijing, Haidian, China
      ChinaPLAGH
    Apr 18, 2023

    NK-T-Cell Lymphoma, Extranodal Trial (Pegaspargase Combined With Gemcitabine, Etoposide, Liposomal Mitoxantrone Hydrochloride

    Not yet recruiting
    • NK-T-Cell Lymphoma, Extranodal
    • Pegaspargase Combined With Gemcitabine, Etoposide, Liposomal Mitoxantrone Hydrochloride and Dexamethasone (P-GEMD) regimen
    • (no location specified)
    Mar 7, 2023

    Extranodal NK/T-cell Lymphoma Trial (Sugemalimab, Placebo, Pegaspargase)

    Not yet recruiting
    • Extranodal NK/T-cell Lymphoma
    • Sugemalimab
    • +4 more
    • (no location specified)
    Jan 17, 2023

    Hematologic Malignancies Trial in Hangzhou (RD13-01 cell infusion)

    Completed
    • Hematologic Malignancies
    • RD13-01 cell infusion
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital，College of Medicine, Zhejiang Univ
    Jan 8, 2022

    NK/T-cell Lymphoma Trial in Shanghai (Positron Emission Tomography/Magnetic Resonance (PET/MR))

    Not yet recruiting
    • NK/T-cell Lymphoma
    • Positron Emission Tomography/Magnetic Resonance (PET/MR)
    • Shanghai, Shanghai, China
      Ruijin Hospital
    Dec 14, 2022

    Synovial Sarcoma Trial in Houston (Fludarabine phosphate, NY-ESO-1 TCR/IL-15 NK, Cyclophosphamide)

    Not yet recruiting
    • Synovial Sarcoma
    • Fludarabine phosphate
    • +2 more
    • Houston, Texas
      MD Anderson Cancer Center
    Oct 9, 2023

    NK/T Cell Lymphoma, Vascular Immunomother T Cell Lymphoma, Non-Hodgkin Lymphoma Trial in Guangzhou (GNC-038)

    Not yet recruiting
    • NK/T Cell Lymphoma
    • +2 more
    • Guangzhou, Guangdong, China
    • +1 more
    Jan 12, 2023

    Extranodal NK/T Cell Lymphoma, Nasal Type Trial in Guangdong (IBI318(Recombinant human anti-PD1/PD-L1 bispecific antibody))

    Active, not recruiting
    • Extranodal NK/T Cell Lymphoma, Nasal Type
    • IBI318(Recombinant human anti-PD1/PD-L1 bispecific antibody)
    • Guangdong, China
      Sun Yat-sen University Cancer Center
    Oct 10, 2022

    Lymphoma Trial (Tislelizumab)

    Not yet recruiting
    • Lymphoma
    • (no location specified)
    Jul 28, 2022

    Aggressive NK Cell Leukemia Trial in Hiroshima (PPMX-T003)

    Recruiting
    • Aggressive NK Cell Leukemia
    • Hiroshima, Japan
      Hiroshima University Hospital
    May 9, 2023

    T-cell Non-Hodgkin Lymphoma, Lymphoma, Extranodal NK-T-Cell Trial in Busan, Daegu (Busulfan, Fludarabine)

    Recruiting
    • T-cell Non-Hodgkin Lymphoma
    • Lymphoma, Extranodal NK-T-Cell
    • Busan, Korea, Republic of
    • +1 more
    Aug 17, 2022

    Hemophagocytic Syndrome, T/NK-Cell Lymphoma Trial in Zhengzhou (Ruxolitinib, Etoposide, Dexamethasone, Gemcitabine,

    Recruiting
    • Hemophagocytic Syndrome
    • T/NK-Cell Lymphoma
    • Ruxolitinib, Etoposide, Dexamethasone, Gemcitabine, Pegaspargase, cis-platinum
    • Zhengzhou, Henan, China
      Oncology Department of The First Affiliated Hospital of Zhengzho
    Aug 3, 2021

    Acute Myeloid Leukemia in Children Trial in Saint Louis (CIML NK Cell Infusion, CD3+ T Cell Product Infusion)

    Recruiting
    • Acute Myeloid Leukemia in Children
    • CIML NK Cell Infusion
    • CD3+ T Cell Product Infusion
    • Saint Louis, Missouri
      Washington University School of Medicine
    Oct 26, 2022

    T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

    Recruiting
    • T-cell Lymphoma
    • +30 more
    • Optional Blood Sample
    • Optional Nail Sample
    • Duarte, California
    • +25 more
    Jul 28, 2023

    T-Cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Angioimmunoblastic T-cell Lymphoma Trial in Saint Louis (WU-CART-007)

    Not yet recruiting
    • T-Cell Non-Hodgkin Lymphoma
    • +14 more
    • WU-CART-007
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jan 17, 2023

    Extranodal NK/T-cell Lymphoma Trial in Bangkok (B-MAD chemo)

    Active, not recruiting
    • Extranodal NK/T-cell Lymphoma
    • B-MAD chemotherapy
    • Bangkok, Thailand
      King Chulalongkorn Memorial Hospital
    May 7, 2022

    Lymphoma, Extranodal NK-T-Cell Trial in Shanghai (Pembrolizumab, Involved Field Radiation Therapy)

    Recruiting
    • Lymphoma, Extranodal NK-T-Cell
    • Shanghai, China
      Shanghai Rui-Jin Hospital
    Mar 29, 2022

    Extranodal NK/T Cell Lymphoma Trial in Nanjing (Pegaspargase(P-GOD), Pegaspargase(PEMD))

    Not yet recruiting
    • Extranodal NK/T Cell Lymphoma
    • Nanjing, Jiangsu, China
      Hematological Department, People's Hospital of Jiangsu Province
    Jun 16, 2022

    Mature T-Cell and NK-Cell Tumor Trial in Hwasun-gun (Copanlisib, Gemcitabine)

    Completed
    • Mature T-Cell and NK-Cell Neoplasm
    • Hwasun-gun, Jeollanam-do, Korea, Republic of
      Chonnam National University Hwasun Hospital
    Jun 9, 2022

    Peripheral T Cell Lymphoma, PTCL, Extranodal NK/T-cell Lymphoma Trial in Worldwide (Tislelizumab)

    Completed
    Has Results
    • Peripheral T Cell Lymphoma
    • +18 more
    • Vancouver, British Columbia, Canada
    • +29 more
    Apr 29, 2022